TY - JOUR
T1 - The role of passive immunization in the age of SARS-CoV-2
T2 - An update
AU - Fischer, Johannes C.
AU - Zänker, Kurt
AU - Van Griensven, Martijn
AU - Schneider, Marion
AU - Kindgen-Milles, Detlef
AU - Knoefel, Wolfram Trudo
AU - Lichtenberg, Artur
AU - Tamaskovics, Balint
AU - Djiepmo-Njanang, Freddy Joel
AU - Budach, Wilfried
AU - Corradini, Stefanie
AU - Ganswindt, Ute
AU - Häussinger, Dieter
AU - Feldt, Torsten
AU - Schelzig, Hubert
AU - Bojar, Hans
AU - Peiper, Matthias
AU - Bölke, Edwin
AU - Haussmann, Jan
AU - Matuschek, Christiane
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2020/5/13
Y1 - 2020/5/13
N2 - The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.
AB - The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.
KW - Bridge therapy
KW - Convalescent plasma
KW - Covid-19
KW - High risk
KW - Immunology
KW - Intensive care unit
KW - Respiratory failure
UR - http://www.scopus.com/inward/record.url?scp=85084627528&partnerID=8YFLogxK
U2 - 10.1186/s40001-020-00414-5
DO - 10.1186/s40001-020-00414-5
M3 - Review article
C2 - 32404189
AN - SCOPUS:85084627528
SN - 0949-2321
VL - 25
JO - European Journal of Medical Research
JF - European Journal of Medical Research
IS - 1
M1 - 16
ER -